GSK Will Cut Sales Force And Reinvest In R&D If Pfizer Acts First

Company would “welcome” a decision by Pfizer to cut back its sales force, CEO Garnier declares. Analyst reports have ignited market speculation that Pfizer is ready to retool its sales and marketing infrastructure.